Cargando…

Hidden in Heart Failure

Current diagnostic strategies fail to illuminate the presence of rare disease in the heart failure population. One-third of heart failure patients are categorised as suffering an idiopathic dilated cardiomyopathy, while others are labelled only as heart failure with preserved ejection fraction. Thos...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannie, Douglas Ewan, Akhtar, Mohammed Majid, Elliott, Perry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659034/
https://www.ncbi.nlm.nih.gov/pubmed/31360229
http://dx.doi.org/10.15420/ecr.2019.19.2
_version_ 1783439055995797504
author Cannie, Douglas Ewan
Akhtar, Mohammed Majid
Elliott, Perry
author_facet Cannie, Douglas Ewan
Akhtar, Mohammed Majid
Elliott, Perry
author_sort Cannie, Douglas Ewan
collection PubMed
description Current diagnostic strategies fail to illuminate the presence of rare disease in the heart failure population. One-third of heart failure patients are categorised as suffering an idiopathic dilated cardiomyopathy, while others are labelled only as heart failure with preserved ejection fraction. Those affected frequently suffer from delays in diagnosis, which can have a significant impact on quality of life and prognosis. Traditional rhetoric argues that delineation of this patient population is superfluous to treatment, as elucidation of aetiology will not lead to a deviation from standard management protocols. This article emphasises the importance of identifying genetic, inflammatory and infiltrative causes of heart failure to enable patients to access tailored management strategies.
format Online
Article
Text
id pubmed-6659034
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-66590342019-07-29 Hidden in Heart Failure Cannie, Douglas Ewan Akhtar, Mohammed Majid Elliott, Perry Eur Cardiol Heart Failure, Arrhythmias and Cardiomyopathies Current diagnostic strategies fail to illuminate the presence of rare disease in the heart failure population. One-third of heart failure patients are categorised as suffering an idiopathic dilated cardiomyopathy, while others are labelled only as heart failure with preserved ejection fraction. Those affected frequently suffer from delays in diagnosis, which can have a significant impact on quality of life and prognosis. Traditional rhetoric argues that delineation of this patient population is superfluous to treatment, as elucidation of aetiology will not lead to a deviation from standard management protocols. This article emphasises the importance of identifying genetic, inflammatory and infiltrative causes of heart failure to enable patients to access tailored management strategies. Radcliffe Cardiology 2019-07-11 /pmc/articles/PMC6659034/ /pubmed/31360229 http://dx.doi.org/10.15420/ecr.2019.19.2 Text en Copyright © 2019, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/legalcode This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle Heart Failure, Arrhythmias and Cardiomyopathies
Cannie, Douglas Ewan
Akhtar, Mohammed Majid
Elliott, Perry
Hidden in Heart Failure
title Hidden in Heart Failure
title_full Hidden in Heart Failure
title_fullStr Hidden in Heart Failure
title_full_unstemmed Hidden in Heart Failure
title_short Hidden in Heart Failure
title_sort hidden in heart failure
topic Heart Failure, Arrhythmias and Cardiomyopathies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659034/
https://www.ncbi.nlm.nih.gov/pubmed/31360229
http://dx.doi.org/10.15420/ecr.2019.19.2
work_keys_str_mv AT canniedouglasewan hiddeninheartfailure
AT akhtarmohammedmajid hiddeninheartfailure
AT elliottperry hiddeninheartfailure